Frederick G Vogt - Net Worth and Insider Trading
Frederick G Vogt Net Worth
The estimated net worth of Frederick G Vogt is at least $14,740 dollars as of 2024-12-28. Frederick G Vogt is the Interim CEO & General Counsel of Iovance Biotherapeutics Inc and owns about 2,000 shares of Iovance Biotherapeutics Inc (IOVA) stock worth over $14,740. Details can be seen in Frederick G Vogt's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Frederick G Vogt has not made any transactions after 2022-11-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Frederick G Vogt
Frederick G Vogt Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Frederick G Vogt owns 1 companies in total, including Iovance Biotherapeutics Inc (IOVA) .
Click here to see the complete history of Frederick G Vogt’s form 4 insider trades.
Insider Ownership Summary of Frederick G Vogt
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| IOVA | Iovance Biotherapeutics Inc | 2022-11-28 | General Counsel |
Frederick G Vogt Latest Holdings Summary
Frederick G Vogt currently owns a total of 1 stock. Frederick G Vogt owns 2,000 shares of Iovance Biotherapeutics Inc (IOVA) as of November 28, 2022, with a value of $14,740.
Latest Holdings of Frederick G Vogt
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| IOVA | Iovance Biotherapeutics Inc | 2022-11-28 | 2,000 | 7.37 | 14,740 |
Holding Weightings of Frederick G Vogt
Frederick G Vogt Form 4 Trading Tracker
According to the SEC Form 4 filings, Frederick G Vogt has made a total of 2 transactions in Iovance Biotherapeutics Inc (IOVA) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Iovance Biotherapeutics Inc is the acquisition of 1,000 shares on November 28, 2022, which cost Frederick G Vogt around $5,980.
Insider Trading History of Frederick G Vogt
- 1
Frederick G Vogt Trading Performance
GuruFocus tracks the stock performance after each of Frederick G Vogt's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Frederick G Vogt is 47%. GuruFocus also compares Frederick G Vogt's trading performance to market benchmark return within the same time period. The performance of stocks bought by Frederick G Vogt within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Frederick G Vogt's insider trading performs compared to the benchmark.
Performance of Frederick G Vogt
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 37.62 | | | | | |
| Relative Return to S&P 500(%) | 43.27 | | | | | |
Frederick G Vogt Ownership Network
Frederick G Vogt Owned Company Details
What does Iovance Biotherapeutics Inc do?
Who are the key executives at Iovance Biotherapeutics Inc?
Frederick G Vogt is the General Counsel of Iovance Biotherapeutics Inc. Other key executives at Iovance Biotherapeutics Inc include Chief Operating Officer Igor Bilinsky , Chief Financial Officer Jean-marc Bellemin , and VP & Finance Michael Swartzburg .
Iovance Biotherapeutics Inc (IOVA) Insider Trades Summary
Over the past 18 months, Frederick G Vogt made no insider transaction in Iovance Biotherapeutics Inc (IOVA). Other recent insider transactions involving Iovance Biotherapeutics Inc (IOVA) include a net purchase of 10,000,000 shares made by Wayne P. Rothbaum , a net purchase of 260,000 shares made by Merrill A Mcpeak , and a net sale of 50,000 shares made by Ryan D Maynard .
In summary, during the past 3 months, insiders sold 50,000 shares of Iovance Biotherapeutics Inc (IOVA) in total and bought 0 shares, with a net sale of 50,000 shares. During the past 18 months, 50,000 shares of Iovance Biotherapeutics Inc (IOVA) were sold and 10,260,000 shares were bought by its insiders, resulting in a net purchase of 10,210,000 shares.
Iovance Biotherapeutics Inc (IOVA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Iovance Biotherapeutics Inc Insider Transactions
Frederick G Vogt Mailing Address
Above is the net worth, insider trading, and ownership report for Frederick G Vogt. You might contact Frederick G Vogt via mailing address: 2120 Hemlock Rd., West Norriton Pa 19403.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
